Defining A New Player In Atherosclerosis: The Role Of Adventitial Haemangioblasts As An Outside-in Driver Of Plaque Growth And Stability.
Funder
National Health and Medical Research Council
Funding Amount
$728,005.00
Summary
As the underlying cause of heart attack, atherosclerosis is a leading cause of death worldwide. New approaches to treatment are desperately needed and this requires a better understanding of how atherosclerotic plaques form in arteries. This project studies a new population of stem cells that we have discovered in the outer layer of arteries, to determine how they cause plaques to form, so that we can develop new therapies that target these stem cells to more effectively treat atherosclerosis.
Characterising The Function Of Niche-derived Neuregulin 1 In Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$994,246.00
Summary
Colorectal cancer affects thousands of Australians each year. A specialised cell population, named cancer stem cells, continuously produces new tumour cells. Defining mechanisms controlling the behaviour of these unique cells is critical to develop new drugs. We have identified that Neuregulin-1 is a key factor that enhances the action of cancer stem cells. We aim to study how colorectal cancer is mediated and whether targeting Neuregulin-1 is a promising therapeutic option.
Dementias affect a large number of Australians each year with the number of patients expected to triple by 2050. As such, there is need to develop a better model of this debilitating disorder to provide improved treatments. Mesenchymal stem cells, are relatively easy to obtain and grow, and are able to produce the key cell types in the brain. We can use these cells to identify the processes that control the production of brain cells, which will likely provide better treatment of this disease.
Cell Trafficking In A Stem Cell Model For Hereditary Spastic Paraplegia
Funder
National Health and Medical Research Council
Funding Amount
$524,082.00
Summary
Hereditary Spastic Paraplegia (HSP) is a genetic disease passed down in affected families. It is a slowly progressing lower limb paralysis that gradually restricts daily activities until the sufferer is confined to bed. There are no cures. This project investigates patientsÍ stem cells to study how HSP genes cause disease. We will use these stem cells to discover new potential drug therapies.
A Simple Method To Improve Stem Cell Transplant Therapy
Funder
National Health and Medical Research Council
Funding Amount
$831,652.00
Summary
Despite the success of hematopoietic stem cell transplantation and years of promise, almost all other stem cell therapies are considered experimental and remain in preclinical or early-phase clinical testing. This study aims to improve the efficiency of stem cell transplantation by manipulating cellular metabolism prior to transplantation, if effective these results may offer hope to patients suffering from a broad range of disorders.
How Does The Endometrium Regenerate? Role Of Epithelial Stem/progenitor Cells
Funder
National Health and Medical Research Council
Funding Amount
$663,397.00
Summary
Endometriosis and endometrial cancer are disorders of endometrial growth and regeneration. We recently discovered adult stem cells in the endometrium (uterine lining), which are responsible for its regeneration each month during the menstrual cycle. We aim to examine the role of a molecular pathway in endometrial epithelial stem cell function during endometrial regeneration to identify novel targets for devising more effective non-hormonal therapies for endometriosis and endometrial cancer.
A Cellular Identity Crisis: Deciphering How Mammary Epithelial Cells Form And Maintain Their Identity
Funder
National Health and Medical Research Council
Funding Amount
$843,826.00
Summary
The ability to regenerate human organs from adult cells efficiently and without error is a major goal of biomedical research in Australia, with significant economic benefits. As one of the most regenerative organs in a woman's body, the breast is an excellent model to study mechanisms that underpin tissue growth and regrowth. Moreover, as these pathways are often hijacked by cancer, this research has important implications for the development of new targeted therapies to treat breast cancer.
Mediator Kinase As A Therapeutic Target For Wnt/β-catenin Dependent Malignancies
Funder
National Health and Medical Research Council
Funding Amount
$949,907.00
Summary
Colorectal cancer is the third leading cause of cancer mortality in Australia and globally. The Wnt/?-catenin signalling pathway is a well established driver of colon cancer growth in >90% of cases. Using sophisticated genetic screens, we identified CDK8/19 as a colon cancer oncogene and critical regulator of Wnt/?-catenin activity. In this proposal, we will use innovative cancer models in mice and human cancer tissues to investigate newly developed CDK8/19 inhibitors for colon cancer therapy ....Colorectal cancer is the third leading cause of cancer mortality in Australia and globally. The Wnt/?-catenin signalling pathway is a well established driver of colon cancer growth in >90% of cases. Using sophisticated genetic screens, we identified CDK8/19 as a colon cancer oncogene and critical regulator of Wnt/?-catenin activity. In this proposal, we will use innovative cancer models in mice and human cancer tissues to investigate newly developed CDK8/19 inhibitors for colon cancer therapy.Read moreRead less